论文部分内容阅读
目的探讨分析胺碘酮治疗左心衰竭合并快速心房颤动(房颤)的临床效果。方法 60例左心衰竭并快速房颤患者,随机分为对照组和研究组,每组30例。对照组采用常规抗心力衰竭药物进行治疗,研究组在对照组基础上加用胺碘酮进行治疗。比较两组患者的临床治疗效果。结果治疗后,研究组收缩压、舒张压、平均动脉压以及心率指标分别为(118.21±9.42)mm Hg(1 mm Hg=0.133 kPa)、(62.43±12.32)mm Hg、(115.31±16.82)mm Hg、(70.61±9.84)次/min,均优于对照组的(136.47±9.24)mm Hg、(68.69±10.95)mm Hg、(130.57±20.15)mm Hg、(150.46±18.37)次/min,差异具有统计学意义(P<0.05)。研究组治疗总有效率为90.00%,明显高于对照组的66.67%,差异具有统计学意义(P<0.05)。在并发症方面,两组均未出现明显并发症。结论在临床上,对左心衰竭并快速房颤进行治疗时,采用胺碘酮的临床效果较好,可以有效改善患者各类指标,临床上应用此方式,可以推广应用。
Objective To investigate the clinical effect of amiodarone in the treatment of left atrial failure complicated with atrial fibrillation (AF). Methods Sixty patients with left ventricular failure and rapid atrial fibrillation were randomly divided into control group and study group, 30 cases in each group. Control group with conventional anti-heart failure drugs for treatment, the study group in the control group based on the use of amiodarone for treatment. The clinical effects of the two groups were compared. Results After treatment, systolic blood pressure, diastolic blood pressure, mean arterial pressure and heart rate were (118.21 ± 9.42) mm Hg (1 mm Hg = 0.133 kPa), (62.43 ± 12.32) mm Hg and (115.31 ± 16.82) mm (70.61 ± 9.84) times / min were significantly higher than those of the control group (136.47 ± 9.24 mm Hg, 68.69 ± 10.95 mm Hg, 130.57 ± 20.15 mm Hg, 150.46 ± 18.37 hpm, The difference was statistically significant (P <0.05). The total effective rate of the study group was 90.00%, which was significantly higher than 66.67% of the control group, the difference was statistically significant (P <0.05). In terms of complications, no significant complications occurred in either group. Conclusions Clinically, the clinical effect of amiodarone when treating left ventricular failure and rapid atrial fibrillation is good, which can effectively improve various indexes of patients. The clinical application of this method can be popularized and applied.